Skip to content
Symeres logo — Thinking ahead. Delivering above.

Symeres

Thinking ahead. Delivering above.

Founded 1987 The Netherlands The Netherlands 502 employees Late Stage Biotechnology, Manufacturing +1

General Information

Company Name Symeres
Founded Year 1987
Location The Netherlands The Netherlands
Employees 502
Industries Biotechnology, Manufacturing, Pharmaceutical
Funding Stage Late Stage
Social

BounceWatch is an independent company data service, not affiliated with Symeres. To contact Symeres, visit symeres.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Symeres compare?

A PDF of Symeres and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Symeres soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Symeres

MercachemSyncom is a transatlantic Contract Research Organization specializing in drug discovery and development, with a focus on making molecules matter. The company, founded in 2017, is headquartered in The Netherlands and boasts around 600 highly educated scientists across six locations in Europe and two in the USA. Their expertise spans early stage hit finding to the delivery of early clinical drug substance API. MercachemSyncom positions itself as large enough to matter, yet small enough to care, offering best-in-class solutions for drug discovery and drug development in the Biotechnology, Manufacturing, and Pharmaceutical industries. With a clear slogan of "Making Molecules Matter. Together.", the company blends vast scientific knowledge with inventiveness to make significant strides in the industry. Despite the absence of publicly available information on their last investment and investors, MercachemSyncom's strong foothold in the drug development space and its transatlantic reach make it a compelling candidate for potential venture capital consideration.

Business keywords: Chemistry, Drug discovery, Contract research organization, European, Nijmegen, Groningen, Prague, Mid-sized organization, Cutting-edge solutions, Chemistry challenges, Chemical research, Netherlands, Czech Republic

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Buyout Undisclosed 1
Keensight Capital
01 May 2021

Symeres Alternatives & Competitors

View All Alternatives
Symeres vs

DIANA Biotechnologies: Diversified Biotech

Seed
60 employees
Biopharma, Biotechnology
Symeres vs

Contract Research Organization / Contract Develop Manufacturing Organization (CRO/CDMO)

2040 employees
Biotechnology, Pharmaceutical
Symeres vs

Advancing Human Health with Pioneering Chemistry. Committed to Innovation, Quality, and Your R&D Suc...

45 employees
Biotechnology, Life Sciences

FAQ About Symeres

Thinking ahead. Delivering above.
Symeres was founded in 1987.
Symeres is headquartered in The Netherlands.
Symeres operates in Biotechnology, Manufacturing and Pharmaceutical. Its work centres on Chemistry, Drug discovery, Contract research organization and European.
Symeres has approximately 502 employees.
Symeres has completed 1 funding round. The latest funding stage is Late Stage.
Top alternatives and competitors to Symeres include DIANA Biotechnologies, Anthem Biosciences Private Limited, Taros Discovery, Sundia MediTech Co., Ltd., CanAm Bioresearch Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Symeres and DIANA Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Symeres, https://bouncewatch.com/company/mercachemsyncom, updated 28 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout